Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr;151(4):895-897.
doi: 10.1016/j.jaci.2023.02.007. Epub 2023 Feb 21.

COVID-19-induced olfactory loss

Boris A Stuck  1 , Susanne Menzel  2 , Martin Laudien  3 , Constantin A Hintschich  4 , Thomas Hummel  2
Affiliations
Editorial

COVID-19-induced olfactory loss

Boris A Stuck et al. J Allergy Clin Immunol. 2023 Apr.
No abstract available

Keywords: Hyposmia; SARS; anosmia; corona virus; smell.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Summary of the pathophysiology, prevalence, time course, and treatment options in COVID-19–induced OD. MRI, Magnetic resonance imaging. Figure adapted in part from Doty RL. OD in COVID-19: Pathology and long-term implications for brain health. Trends Mol Med 2022;28:781-94.
See this image and copyright information in PMC

References

    1. Hannum M.E., Ramirez V.A., Lipson S.J., Herriman R.D., Toskala A.K., Lin C., et al. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective methods: a systematic review and meta-analysis. Chem Senses. 2020;45:865–874. - PMC - PubMed
    1. Patel Z.M., Holbrook E.H., Turner J.H., Adappa N.D., Albers M.W., Altundag A., et al. International consensus statement on allergy and rhinology: olfaction. Int Forum Allergy Rhinol. 2022;12:327–680. - PubMed
    1. von Bartheld C.S., Hagen M.M., Butowt R. Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences. ACS Chem Neurosci. 2020;19:2944–2961. - PMC - PubMed
    1. Whitaker M., Elliott J., Bodinier B., Barclay W., Ward H., Cooke G., et al. Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England. Nat Commun. 2022;13:6856. - PMC - PubMed
    1. Karamali K., Elliott M., Hopkins C. COVID-19 related olfactory dysfunction. Curr Opin Otolaryngol Head Neck Surg. 2022;30:19–25. - PMC - PubMed

Publication types